Also probably worth mentioning that strain preference is quite important. Word of mouth and user reviews play a large role in this as well.
We only advertise the THC and CBD content of certain strains (at the moment). But, there are anywhere from 80 - 140 cannabinoids & up to 300 non-cannabinoid compounds found in cannabis plants.
Maybe in my lifetime there may be products marketed identifying these compounds and marketing their unique therapeutic profiles. But for now, it’s just the two. Having registered and unique strains that my be able to tap into this could drive a future of expanded ranges and a wider scope of treatment.
Also probably worth mentioning that strain preference is quite...
Add ECS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $20.61M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.7¢ | 1.6¢ | $48.29K | 3.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 4228498 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.7¢ | 1123625 | 3 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.6¢ |
Change
-0.001 ( 5.88 %) |
||||
| Open | High | Low | Volume | ||
| 1.6¢ | 1.6¢ | 1.5¢ | 1446163 | ||
| Last updated 13.07pm 13/06/2024 ? | |||||
| ECS (ASX) Chart |